A study published in Cephalalgia, titled Characteristics of visual snow syndrome in Japan and its association with migraine, provides new insight into Visual Snow Syndrome (VSS) and its relationship with migraine in Japan. The Visual Snow Initiative provided funding for the publication of the paper, which compared 148 people with VSS and 157 control participants to better understand how migraine may relate to the visual symptoms experienced by people with VSS.
The researchers explored several questions, including:
- Whether migraine was more common among people with VSS
- Whether migraine was associated with particular VSS symptoms
- Whether people with VSS had larger differences in prescription strength between their two eyes
- Whether VSS symptoms changed over time
The findings showed that migraine was substantially more common among people with VSS and was associated with palinopsia, which can include persistent afterimages. Migraine aura was associated with both palinopsia and enhanced entoptic phenomena.
Researchers also found larger differences in prescription strength between the eyes among participants with VSS, although this finding remains preliminary and requires further investigation.
Taken together, the results add to the growing evidence that VSS and migraine frequently occur together, while also raising new questions about whether certain visual characteristics are more common in people with VSS.
Why Study Migraine in Visual Snow Syndrome?
Visual Snow Syndrome is characterized by continuous, flickering dots across the visual field, often described as resembling television static. However, visual snow itself is only one part of the condition.
People with VSS may also experience:
- Palinopsia, including persistent afterimages
- Photophobia, or increased sensitivity to light
- Difficulty seeing at night
- Enhanced entoptic phenomena
Because these symptoms can vary considerably from person to person, researchers are continuing to investigate why certain symptoms occur together and whether other neurological conditions may influence how VSS is experienced.
Migraine is one of the most commonly reported conditions alongside VSS. Migraine can also affect visual and sensory processing, making the overlap between the two conditions particularly important to study.
By comparing migraine history with individual VSS symptoms, the researchers hoped to better understand whether certain visual experiences were more common among people who also had migraine or migraine aura.
How Was the Study Conducted?
The researchers reviewed previously collected clinical information from 148 people with VSS and compared it with data from 157 participants without VSS.
The two groups had similar ages and proportions of men and women, helping make the comparisons between them more meaningful.
The researchers examined:
- Participants’ history of migraine and migraine aura
- The visual symptoms reported by people with VSS
- Eye examination measurements
- The prescription strength required by each eye
- Differences in prescription strength between the two eyes
- Changes in VSS symptoms over at least six months of follow-up
Because this was a retrospective study, the researchers were examining patterns within information that had already been collected.
What Did the Researchers Find?
One of the clearest findings was the difference in migraine frequency between the two groups.
Migraine was reported by 61.5% of people with VSS, compared with 21.7% of control participants.
The researchers then looked more closely at whether migraine was associated with particular VSS symptoms.
They found that:
- Migraine was associated with palinopsia
- Migraine aura was associated with palinopsia
- Migraine aura was also associated with enhanced entoptic phenomena
These findings suggest that some visual symptoms may occur more frequently in people who experience both VSS and migraine. However, they do not show that migraine causes these symptoms or that treating migraine would necessarily cause them to disappear.
Other visual symptoms were also very common among participants with VSS. Photophobia and difficulty seeing at night were each reported by 81.8% of people with VSS.
Exploring Differences Between the Eyes
The study also examined whether people with VSS were more likely to have differences in prescription strength between their two eyes. The researchers found larger differences between the eyes among participants with VSS compared with controls.
This type of difference is known as anisometropia. Anisometropia means that the two eyes require different prescriptions. For example, one eye may be more nearsighted or farsighted than the other, or the two eyes may have different amounts of astigmatism.
When this difference is not corrected, one eye may receive a clearer image while the other receives a blurrier one. The finding is interesting because it introduces another visual characteristic that may be worth studying in VSS.
The study does not show that unequal prescriptions between the eyes cause VSS. It also does not establish that correcting anisometropia would improve or resolve VSS symptoms.
Instead, the finding raises another question for future research: whether differences in the visual input received by each eye are more common in people with VSS and whether those differences have any clinical significance.
What Does This Mean for Future Research?
The study adds further evidence that migraine is common among people with Visual Snow Syndrome and may be associated with particular symptoms, including palinopsia and enhanced entoptic phenomena.
It also raises a newer question about whether differences in prescription strength between the two eyes may occur more frequently in people with VSS.
At the same time, the researchers noted important limitations.
Participants were recruited through information on the institution’s website, which may have attracted more younger people who were comfortable searching for health information online. Because of this, the study population may not fully represent everyone with VSS, particularly older people or those who seek information or medical care in different ways.
Future research could build on these findings by:
- Studying larger and more diverse groups of people with VSS
- Tracking symptoms consistently over longer periods of time
- Comparing people with VSS who have migraine, migraine aura, or no migraine
- Investigating differences between the eyes in larger patient groups
- Testing specific treatments or interventions in controlled studies
For the VSS community, studies like this help clarify which features commonly occur together while also showing where important questions remain.
The findings support continued research into the relationship between VSS and migraine, while reinforcing the need to distinguish an association from evidence of cause or treatment benefit.